Search results
Why Is Verve Therapeutics, Inc. (VERV) the Most Shorted Stock Loved by Analysts Now?
Insider Monkey via Yahoo Finance UK· 16 minutes agoWe recently compiled a list of the 10 Most Shorted Stocks That Are Loved by Analysts. In this...
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials
The Independent· 1 hour agoTirzepatide, which is sold under the brand names Mounjaro and Zepbound – which treat diabetes and...
S&P 500 Ekes Out Gain to Notch 35th Record in 2024: Markets Wrap
Bloomberg via Yahoo Finance UK· 3 hours ago(Bloomberg) -- Stocks closed at all-time highs in a cautious session that saw traders gearing up for...
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance UK· 7 hours agoEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
Zacks via Yahoo Finance UK· 7 hours agoEmploying factors like one-week price change and the monthly percentage change in earnings...
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance UK· 7 hours agoAnother thing that can drive investing is the fear of missing out, or FOMO. This particularly...
Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal
Bloomberg via Yahoo Finance UK· 8 hours ago(Bloomberg) -- Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2...
Lilly beefs up bowel disease drug portfolio with $3.2 bln Morphic deal
Reuters· 9 hours agoEli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday,...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance UK· 9 hours agoThis ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking at...
British Patient Capital invests £90m London biotech company
CityAM via Yahoo Finance UK· 9 hours agoFund: Breakthrough programme. The funding round was co-led by life science investors Novo Holdings...